Skip to content

Investigating the effects of berberis vulgaris L. on the treatment of opiate withdrawal syndrome

Investigating the effects of berberis vulgaris L. on the treatment of opiate withdrawal syndrome

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180114038356N3
Enrollment
28
Registered
2020-07-16
Start date
2019-04-19
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients addicted to opioids treated with methadone. Mental and behavioural disorders due to use of opioids

Interventions

Intervention 1: Intervention group: 28 patients under methadone therapy will be assigned to the treatment group to receive the extract (500 mg, twice a day for 30 days). Intervention 2: Control group:

Sponsors

Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Opioid addiction of at least 2.3 grams per day continuously for at least one year, Age between 20-60 years old No history of medical comorbidities No history of allergies to this plant

Exclusion criteria

Exclusion criteria: History of medical comorbidities History of allergies to this plant Do not take the capsules Dissatisfaction with methadone dose reduction Intolerance to some of side effects of the extract, such as dry mouth

Design outcomes

Primary

MeasureTime frame
Examination of opioid withdrawal symptoms and neurological complications with the questionnaires. Timepoint: Before intervention and 7, 14 and 28 days after intervention. Method of measurement: Questionnaires.

Secondary

MeasureTime frame
Assessment of depression, anxiety, sleep quality. Timepoint: Before intervention and 7, 14 and 28 days after intervention. Method of measurement: Questionnaires.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSomayyeh Karami-Mohajeri

Kerman University of Medical Sciences

somayyehkarami@gmail.com+98 34 4142 5001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026